Miami pharma exec, a big Republican donor, agrees to pay up to $50 million to settle Medicaid civil fraud charges

Nostrum Laboratories' carton label on its "Nitro OS" antibacterial medicine. The Justice Department says that Nostrum and CEO Nirmal Mulye have agreed to pay millions to settle civil claims they knowingly underpaid required Medicaid rebates.

By Dan Christensen, FloridaBulldog.org

A Miami businessman who once justified his decision to quadruple the price of a liquid antibiotic his company sold – to more than $2,300 a bottle – by asserting a “moral requirement to sell the product at the highest price” has agreed to pay up to $50 million to settle federal Medicaid civil fraud charges.

How much Nirmal Mulye and his company, Nostrum Laboratories, ultimately will have to pay will be based on their financial condition, federal fraud prosecutors said. The minimum amount they owe in the settlement, however, is $3.825 million.

More Headlines

Florida Supreme Court debate about Marsy's Law and victims’ privacy reflects fiery politics of law enforcement

State ethics commissioner Figgers, a DeSantis favorite, snags million dollar contract from Central Florida tourism district run by ex-colleague

SEC accuses financial empire of Florida Panthers owners Viola, Cifu of fraud

FDLE delays trial that could cost Broward Sheriff Tony his license to be a cop; special interests flood Tony's re-election PAC with huge donations

Support Florida Bulldog

We need your help! If you believe in the value of watchdog journalism please make your tax-deductible contribution today.

We are a 501(c)(3) organization. All donations are tax deductible.

Our mailing address is:
P.O. Box 23763 Fort Lauderdale, FL 33307
Copyright (C) 2023 Florida Bulldog All rights reserved.

Unsubscribe [email protected] from this list (or change email to a different address)

Unsubscribe